Historical HbA


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
07 Jul 2021
Historique:
received: 02 10 2020
accepted: 03 05 2021
pubmed: 11 7 2021
medline: 11 7 2021
entrez: 10 7 2021
Statut: aheadofprint

Résumé

Type 2 diabetes all-cause mortality (ACM) and myocardial infarction (MI) glycemic legacy effects have not been explained. We examined their relationships with prior individual HbA Twenty-year ACM and MI hazard functions were estimated from diagnosis of type 2 diabetes in 3,802 UK Prospective Diabetes Study participants. Impact of HbA Hazard ratios for a one percentage unit higher HbA The glycemic legacy effects seen in type 2 diabetes are explained largely by historical HbA

Identifiants

pubmed: 34244332
pii: dc20-2439
doi: 10.2337/dc20-2439
pmc: PMC8740943
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2021 by the American Diabetes Association.

Références

Diabetologia. 1991 Dec;34(12):877-90
pubmed: 1778353
N Engl J Med. 2005 Dec 22;353(25):2643-53
pubmed: 16371630
N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
Lancet. 2013 Jul 27;382(9889):339-52
pubmed: 23727170
Lancet. 1998 Sep 12;352(9131):854-65
pubmed: 9742977
J Clin Endocrinol Metab. 2009 Feb;94(2):410-5
pubmed: 19066300
PLoS One. 2009;4(2):e4412
pubmed: 19209233
Diabetes Care. 2020 Jan;43(Suppl 1):S1-S2
pubmed: 31862741
Circ Res. 2016 May 27;118(11):1808-29
pubmed: 27230643
N Engl J Med. 2016 Jul 28;375(4):311-22
pubmed: 27295427
N Engl J Med. 2009 Jan 8;360(2):129-39
pubmed: 19092145
BMJ. 2000 Aug 12;321(7258):405-12
pubmed: 10938048
N Engl J Med. 1993 Sep 30;329(14):977-86
pubmed: 8366922
Ann Intern Med. 2004 Sep 21;141(6):421-31
pubmed: 15381515
Lancet. 1998 Sep 12;352(9131):837-53
pubmed: 9742976
Diabetologia. 2010 Jun;53(6):1093-8
pubmed: 20237754
Diabetes Care. 2010 Aug;33(8):1903-4
pubmed: 20519665
N Engl J Med. 2015 Oct 29;373(18):1720-32
pubmed: 26510021
N Engl J Med. 2019 Jun 6;380(23):2215-2224
pubmed: 31167051
Diabetes Care. 2019 Mar;42(3):416-426
pubmed: 30104301
N Engl J Med. 2008 Jun 12;358(24):2545-59
pubmed: 18539917
Diabetologia. 2013 Dec;56(12):2601-8
pubmed: 24114114
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792
pubmed: 32687793
Curr Diab Rep. 2012 Oct;12(5):551-9
pubmed: 22760445
Diabetes Metab Res Rev. 2016 Oct;32(7):730-735
pubmed: 26888448
Open Heart. 2019 Sep 9;6(2):e000967
pubmed: 31565231
N Engl J Med. 2008 Oct 9;359(15):1577-89
pubmed: 18784090
Diabetologia. 2009 Nov;52(11):2288-98
pubmed: 19655124
N Engl J Med. 2008 Jun 12;358(24):2560-72
pubmed: 18539916
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833
pubmed: 32798471

Auteurs

Marcus Lind (M)

Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden marcus.lind@gu.se.
Department of Medicine, NU-Hospital Group, Uddevalla, Sweden.

Henrik Imberg (H)

Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden.

Ruth L Coleman (RL)

Diabetes Trials Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.

Olle Nerman (O)

Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden.

Rury R Holman (RR)

Diabetes Trials Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.

Classifications MeSH